![](/img/cover-not-exists.png)
Exposure-response of olaratumab for survival outcomes and safety when combined with doxorubicin in soft tissue sarcoma (STS) patients
Jones, R., Mo, G., Baldwin, J.R., Nichols, R.D., Ilaria, R.L., Conti, I., Cronier, D.M., Tap, W.D.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw388.08
Date:
October, 2016
File:
PDF, 39 KB
english, 2016